Company Profile
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specialty Insurance, ERGO Life and Health Germany, ERGO Property-Casualty Germany, and ERGO International. The company offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, data analytics, underwriting and claims, medical research, capital management, and health market, as well as MIRA digital suite that includes MIRA PoS, MIRApply insured and physician, claims risk assessment, and CLARA plus. It also provides property and casualty reinsurance solutions, including agricultural reinsurance; business advisory, personal lines, portfolio management, insurance consulting, commercial motor consulting; infrastructure risk; property insurance, location risk, insurance linked securities, and NatCatSERVICE for natural catastrophe loss database; prospective structured and retroactive reinsurance; risk transfer; cyber; and data analytics, REALYTIX ZERO, and cert2go. In addition, the company offers solutions for industry clients, such as corporate risk, new tech, green tech, parametric, and aviation and space solutions, as well as risk services. Further, it provides specialty property casualty insurance, such as professional liability, marine, cyber, aviation, and space for commercial and private customers. Additionally, the company offers life, property-casualty, health, legal protection, and travel insurance products under the ERGO brand; and insurance solutions for agriculture, captive, epidemic, cyber, and renewable energy sectors. The company was founded in 1880 and is based in Munich, Germany.
Latest News
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
Netflix Is Down 41% in 1 Year. Could the Sell-Off Be Nearing an End?
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
| Sector | Financial Services |
| Industry | Insurance - Reinsurance |
| Website | https://www.munichre.com |
| Audit Risk | 2 |
| Board Risk | 4 |
| Overall Risk | 2 |
| Market Cap | 66.03B |
| Trailing P/E | 9.88 |
| Forward P/E | 9.93 |
| Dividend Rate | 24 |
| Dividend Yield | 4.72% |
| Trailing Annual Div. Rate | 24 |
| Trailing Annual Div. Yield | 4.72% |
| Trailing EPS | 52.22 |
| Forward EPS | 51.99 |
| Book Value | 270.39 |
| Price-to-Book | 1.91 |
| Enterprise-to-Revenue | 1.09 |
| Ex-Dividend Date | 04/30/2026 |
| Earnings Date | 08/07/2026 |
| Earnings Call Date | 05/12/2026 |
| Earnings Average | 13.62 |
| Earnings Low | 12.65 |
| Earnings High | 14.5 |
| Revenue Average | 18.13B |
| Revenue Low | 18.13B |
| Revenue High | 18.13B |